BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11817595)

  • 21. Annual direct and indirect health care costs of chronic idiopathic urticaria: a cost analysis of 50 nonimmunosuppressed patients.
    Delong LK; Culler SD; Saini SS; Beck LA; Chen SC
    Arch Dermatol; 2008 Jan; 144(1):35-9. PubMed ID: 18209166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in economic consequences of rheumatoid arthritis over two subsequent years.
    Verstappen SM; Jacobs JW; Kruize AA; Ehrlich JC; van Albada-Kuipers GA; Verkleij H; Buskens E; Bijlsma JW
    Rheumatology (Oxford); 2007 Jun; 46(6):968-74. PubMed ID: 17337750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determinants of direct costs in Dutch rheumatoid arthritis patients.
    Verstappen SM; Verkleij H; Bijlsma JW; Buskens E; Kruize AA; Heurkens AH; Van Der Veen MJ; Jacobs JW
    Ann Rheum Dis; 2004 Jul; 63(7):817-24. PubMed ID: 15194577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for work disability in patients with ankylosing spondylitis.
    Ward MM; Kuzis S
    J Rheumatol; 2001 Feb; 28(2):315-21. PubMed ID: 11246669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of functional disability using the health assessment questionnaire in Japanese patients with systemic sclerosis.
    Kuwana M; Sato S; Kikuchi K; Kawaguchi Y; Fujisaku A; Misaki Y; Hatamochi A; Kondo H; Takehara K
    J Rheumatol; 2003 Jun; 30(6):1253-8. PubMed ID: 12784399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Burden and cost of illness in patients with juvenile idiopathic arthritis.
    Minden K; Niewerth M; Listing J; Biedermann T; Schöntube M; Zink A
    Ann Rheum Dis; 2004 Jul; 63(7):836-42. PubMed ID: 15194580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct and indirect costs associated with the onset of seropositive rheumatoid arthritis. Western Consortium of Practicing Rheumatologists.
    Newhall-Perry K; Law NJ; Ramos B; Sterz M; Wong WK; Bulpitt KJ; Park G; Lee M; Clements P; Paulus HE
    J Rheumatol; 2000 May; 27(5):1156-63. PubMed ID: 10813281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany.
    Huscher D; Merkesdal S; Thiele K; Zeidler H; Schneider M; Zink A;
    Ann Rheum Dis; 2006 Sep; 65(9):1175-83. PubMed ID: 16540552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Costs and course of disease and function in early rheumatoid arthritis: a 3-year follow-up (the Swedish TIRA project).
    Hallert E; Husberg M; Skogh T
    Rheumatology (Oxford); 2006 Mar; 45(3):325-31. PubMed ID: 16287927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of flare on disease costs of patients with systemic lupus erythematosus.
    Zhu TY; Tam LS; Lee VW; Lee KK; Li EK
    Arthritis Rheum; 2009 Sep; 61(9):1159-67. PubMed ID: 19714597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cost of diabetes in Latin America and the Caribbean.
    Barceló A; Aedo C; Rajpathak S; Robles S
    Bull World Health Organ; 2003; 81(1):19-27. PubMed ID: 12640472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indirect cost assessment in patients with rheumatoid arthritis (RA): comparison of data from the health economic patient questionnaire HEQ-RA and insurance claims data.
    Merkesdal S; Ruof J; Huelsemann JL; Mittendorf T; Handelmann S; Mau W; Zeidler H
    Arthritis Rheum; 2005 Apr; 53(2):234-40. PubMed ID: 15818718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The economic burden of rheumatoid arthritis in a developing nation: results from a one-year prospective cohort study in Thailand.
    Osiri M; Maetzel A; Tugwell P
    J Rheumatol; 2007 Jan; 34(1):57-63. PubMed ID: 17183621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The burden of ankylosing spondylitis.
    Boonen A; van der Linden SM
    J Rheumatol Suppl; 2006 Sep; 78():4-11. PubMed ID: 17042055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost effectiveness of combined spa-exercise therapy in ankylosing spondylitis: a randomized controlled trial.
    Van Tubergen A; Boonen A; Landewé R; Rutten-Van Mölken M; Van Der Heijde D; Hidding A; Van Der Linden S
    Arthritis Rheum; 2002 Oct; 47(5):459-67. PubMed ID: 12382292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The direct healthcare costs associated with ankylosing spondylitis patients attending a UK secondary care rheumatology unit.
    Ara RM; Packham JC; Haywood KL
    Rheumatology (Oxford); 2008 Jan; 47(1):68-71. PubMed ID: 18077492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimating the cost of cancer: results on the basis of claims data analyses for cancer patients diagnosed with seven types of cancer during 1999 to 2000.
    Chang S; Long SR; Kutikova L; Bowman L; Finley D; Crown WH; Bennett CL
    J Clin Oncol; 2004 Sep; 22(17):3524-30. PubMed ID: 15337801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Work disability in rheumatoid arthritis--development over 15 years and evaluation of predictive factors over time.
    Eberhardt K; Larsson BM; Nived K; Lindqvist E
    J Rheumatol; 2007 Mar; 34(3):481-7. PubMed ID: 17299844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in Health Assessment Questionnaire disability scores over five years in patients with rheumatoid arthritis compared with the general population.
    Sokka T; Kautiainen H; Hannonen P; Pincus T
    Arthritis Rheum; 2006 Oct; 54(10):3113-8. PubMed ID: 17009231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implementation of social services for the chronically mentally ill in a Polish mental health district: consequences for service use and costs.
    Zaluska M; Suchecka D; Traczewska Z; Paszko J
    J Ment Health Policy Econ; 2005 Mar; 8(1):37-44. PubMed ID: 15870484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.